Our Approach

Viral outbreaks do not wait for countermeasure development.

Early interventions:
Infection contained with few treated

Delayed countermeasures:
infection spreads and becomes increasingly harder to control

Viral outbreaks do not wait for countermeasure development.

We are proactively charting defense against current and future viral enemies, with a resource-effective strategy focused on prototypes from viral families of pandemic potential.

Our resource-effective strategy to chart defenses against 1000’s of human-infecting viruses with prototype viruses.

Learn more about our prototype viruses and the viral-most-wanted families they represent.

Building better vaccines with data-driven AI-enabled insights into viral structures and immunity

Learn more about structure-based vaccine design by the lead of our Structural Biology Core and MacArthur Genius Award Winner Jason McLellan and the pioneering work of Jishnu Das in leveraging AI and machine learning for immunological advances.

R2P2 is part of the ReVAMPP research network.
The content of this website is the sole responsibility of the authors and does not purport to represent the official views of the National Institutes of Health.